TheProfitWatch

GALT - Galectin Therapeutics Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.05 -0.43 (-8.51%) --- --- --- 0.03 (0.59%) 0.1 (1.98%) 0.0 (0.0%) 0.0 (0.0%)

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-38.5
Diluted P/E:
-38.5
RSI(14) 1m:
0.0
VWAP:
4.62
RVol:

Events

Period Kind Movement Occurred At

Related News